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INTRODUCTION
Humans suffer from various allergic disorders in their life 
time including asthma, systemic allergic disorders and some 
skin disorders. It is difficult to completely cure these disorders. 
Many different kinds of small molecular weight-drugs and re-
cently several biologics such as anti-TNF-a monoclonal an-
tibody are used clinically (Walsh, 2011). However, there is a 
continual need for plant alternative medicine since they are 
relatively safe and cost-effective, and especially the cumula-
tive record of their use over thousands of years exists. In this 
respect, the effect of many plant extracts were examined for 
their anti-allergic activity in our screening procedure, and the 
rhizomes of Acorus gramineus were found to possess some 
anti-allergic activity in vitro.
The rhizome of Acorus gramineus (Araceae) is a well-
known Chinese traditional medicine. This plant material has 
been used widely as antipyretic, memory enhancement, an-
algesia, sedative and digestive in China, Japan and Korea 
(Liao et al., 1998). The major constituents are b-asarone and 
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Abstract
phenylpropenes (Park et al., 2011). There have been many in-
vestigations concerning the effects of this plant material on the 
improvement of brain function (Liao et al., 1998; Chun et al., 
2008), and an anti-allergic property has not been elucidated 
to date. In our preliminary experiment, the ethanol extract of 
the rhizomes of A. gramineus (AGE) were found to possess 
an anti-allergic action although the potency was not strong. 
Therefore, the anti-allergic activity of A. gramineus and the 
constituents was investigated using an in vitro and in vivo ani-
mal model of allergic responses in the present investigation.
MATERIALS AND METHODS
Chemicals
A23187 was obtained from Biomol (Plymouth Meeting, 
PA, USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT), nordi hydroguaiaretic acid (NDGA), predniso-
lone, quercetin, car boxy methylcellulose (CMC), dinitrophenyl 
(DNP)-BSA, anti-DNP mouse IgE and p-nitrophenyl-N-acetyl-
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Fig. 1. Chemical structures of the compounds isolated from the 
rhizomes of A. gramineus. 1: b-asarone, 2: asaraldehyde, 3: pro-
pioveratrone, 4: acoraminol A, 5: acoraminol B, 6: (7S,8R)-dihyd-
rodiconiferyl alcohol (AA), 7: 2,4,5-trimethoxyallylbenzene (AB), 8: 
(2R,3R,4S,5S)-2,4-dimethyl-1,3-bis(2',4',5'-trimethoxyphenyl) tetra-
hydrofuran (AF), 9: 2,3-dihydro-4,5,7-trimethoxy-1-ethyl-2-methyl-
3-(2,4,5-trimethoxyphenyl)indene (AI).
Fig. 2. Inhibition of 5-LOX-catalyzed LT production in A23187-
treated RBL-1 cells by the extracts of A. gramineus and the constit-
uents. (A) Effects of the extracts of A. gramineus on LT production. 
(B) Effects of the selected constituents on LT production. Water 
extract (white), ethanol extract (black), b-asarone (stripe), AF (light 
grey), AI (dark grey). *p<0.05, Significantly different from A23187-
treated control group (n=3). % inhibition = (A23187-treated control 
− sample treatment w/ A23187)/(A23187-treated control − control 
w/o A23187) ×100.
ethyl-2-methyl-3-(2,4,5-trimethoxyphenyl)indene (AI) from the 
MeOH extract of A. gramineus were reported previously (Fig. 
1) (Park et al., 2011). 
Rat basophilic leukemia-1 (RBL-1) cell culture and mea-
surement of leukotriene (LT) concentration
To evaluate the 5-lipoxygenase (5-LOX) inhibitory activity, 
RBL-1 cells purchased from the American Type Culture Col-
lection (ATCC, Rockville, VA, USA) were cultured in RPMI 
1640 with 10% FBS under 5% CO2 at 37
oC. The test com-
pounds were dissolved in DMSO and diluted to appropriate 
concentrations with serum-free DMEM. The final concentra-
tion of DMSO was adjusted to 0.1% (v/v). The cells were pre-
incubated with the test compounds for 10 min. Then, A23187 
(3 mM) was added to activate the 5-LOX and the cells were fur-
ther incubated for 15 min as previously described, with slight 
modification (Tries et al., 2002). The media was then collected 
and the concentration of the 5-LOX product, cysteinyl leukot-
rienes (LTC4/D4/E4), was measured using an ELISA kit (Enzo 
Life Sciences) as recommended by the manufacturer. The cell 
viability was assessed using an MTT assay as previously de-
scribed (Mossman, 1983).
b-D-glucosaminide were purchased from Sigma Chem (St. 
Louis, MO, USA). DMEM and other cell culture reagents in-
cluding FBS were products of Gibco BRL (Grand Island, NY, 
USA). A protein assay kit was purchased from Bio-Rad (Her-
cules, CA, USA). 
Animals 
Male ICR mice (4 weeks old, specific pathogen-free) were 
obtained from Orient-Bio Co. (Korea). The animals were main-
tained in the animal facility (KNU) at 20-22oC under 40-60% 
relative humidity and a 12 h/12 h (light/dark) cycle for at least 
7 days prior to the experiment. The experimental design using 
the animals was approved by the local committee for animal 
experimentation, KNU (KIACUC-11-0007), and the animals 
were handled according to the guidelines described in the 
KFDA Guide for the Care and Use of Laboratory Animals.
Preparation of the extracts of the rhizomes of A. gramin-
eus and isolation of the constituents 
The rhizomes of A. gramineus were collected in Jeju Is-
land, Korea in March 2009, and identified by one of authors 
(Dr. K. R. Lee). A voucher specimen (SKKU-NPL-0910) was 
deposited at the herbarium of the School of Pharmacy, Sung-
kyunkwan University, Suwon, Korea. The dried and chopped 
rhizomes of A. gramineus (150.0 g) were extracted with wa-
ter and 70% EtOH under reflux and then filtered. The filtrates 
were evaporated under reduced pressure to give water extract 
and EtOH extract. These are used for the pharmacological 
assays. For an isolation of active constituents, the rhizome 
parts of A. gramineus (15 kg) were extracted at room tem-
perature with 80% MeOH to give a MeOH extract (1.2 kg). 
The isolation and identification of b-asarone, asaraldehyde, 
propioveratrone, acoraminol A, acoraminol B, 7S,8R-dihy-
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RBL-2H3 cell culture and antigen-induced degranulation 
of β-hexosaminidase
Sensitization and degranulation procedures were followed 
by the previously described procedure (Choi et al., 1996). 
In brief, anti-DNP mouse IgE was added to RBL-2H3 cells 
(ATCC) for sensitization and incubated overnight. Twenty four 
hours later, the cells were washed with siraganian buffer (pH 
7.2). The test compounds dissolved in DMSO were added and 
the cells were incubated for 30 min. Then, DNP-BSA (1 mg/
ml) was added, and after 10 min incubation, the reaction was 
stopped by cooling in an ice bath. The supernatant was ob-
tained by centrifugation. The substrate (1 mM p-nitrophenyl-
N-acetyl-b-D-glucosaminide) was added and incubated for 1 
h at 37oC. The reaction was stopped by adding 0.1 M Na2CO3/
NaHCO3 (200 ml/well). The absorbance was measured at 405 
nm.
Picryl chloride-induced delayed hypersensitivity in mice
For measuring inhibitory activity against delayed type hy-
persensitivity (DTH, type IV hypersensitivity), 7% picryl chlo-
ride (Nacalai Tesque Inc., Japan) in acetone (100 ml/mouse) 
was smeared to the abdomen of mice to sensitize the animals 
for the elicitation phase group. For the animals of the control 
group, acetone (100 ml) was applied instead of picryl chloride. 
Seven days later, the elicitation phase of delayed hypersen-
sitivity was induced by application of 1% picryl chloride in ac-
etone (20 ml/ear) to right ears of the sensitized mice. For ob-
taining the induction phase reaction, 1% picryl chloride (20 ml/
ear) was applied to right ears of acetone-treated mice. For the 
control group, only acetone (20 ml) was applied to right ears 
of acetone-treated mice. After 24 h, ear thickness was mea-
sured. Test compounds dissolved in 0.4% CMC were orally 
administered 1 h after initial treatment of sensitizer or acetone. 
The same amounts of test compounds in vehicle were treated 
again 1 h after final picryl chloride or acetone treatment. 
Statistical analysis 
All data were represented as arithmetic mean ± SD. One-
way analysis of variance (ANOVA), followed by Dunnett’s test 
was used to determine the statistical significance. 
RESULTS 
 
In A23187-treated RBL-1 cells, cysteinyl-LTs (1,811.7 
± 134.5 pg/ml) were synthesized by 5-LOX for 15 min. The 
basal level of the cysteinyl-LTs without A23187 treatment was 
50.3 ± 18.9 pg/ml (n=3). Under these conditions, the water 
and ethanol extracts considerably inhibited LT production at 
12.5-200 mg/ml (Fig. 2A). The IC50 values for the water and 
ethanol extracts were 120.0 and 48.9 mM, respectively. When 
the constituents were tested, b-asarone, AF and AI showed a 
strong inhibitory action (Fig. 2B), while AB showed weak inhi-
bition. Their IC50 values were represented in Table 1. NDGA 
(LOX inhibitor, 1 mM) used as a reference strongly inhibited LT 
production (99.3%). 
In antigen-treated RBL-2H3 cells, b-hexosaminidase was 
degranulated and released into the media for a 10 min incu-
bation period (from 0.0 ± 3.2% to 100.0 ± 1.2%, n=3). Under 
these conditions, the ethanol extract of A. gramineus signifi-
cantly inhibited the degranulation reaction at 50-200 mg/ml 
(Fig. 3A). The ethanol extract showed 31.4% inhibition at 200 
Fig. 3. Inhibition of b–hexosaminidase degranulation in antigen-
treated RBL-2H3 cells by the extracts of A. gramineus and the 
constituents. (A) Effects of the extracts of A. gramineus on b–hex-
osaminidase degranulation. (B) Effects of the selected constituents 
on b–hexosaminidase degranulation. Water extract (white), ethanol 
extract (black), b-asarone (stripe), AF (light grey), AI (dark grey), 
*p<0.05, Significantly different from antigen-treated control group 
(n=3). % inhibition = (antigen-treated control − sample treatment w/
antigen)/(antigen-treated control − control w/o antigen) ×100.
Table 1. Inhibition of the constituents of the rhizomes of A. gramineus 
against 5-LOX catalyzed LT production and b-hexosaminidase degranu-
lation
Compounds





























a)All values are arithmetic mean of % inhibition at 50 mM, n=3, b)The 
values of the parenthesis are IC50 vales in mM. 
c)not active, ctcyto-
toxic at 2-50 mM by MTT assay.
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mg/ml, while the water extract did not show significant inhibi-
tory action at 50-200 mg/ml. When the inhibitory action of the 
constituents was examined, only AI showed strong inhibitory 
activity (Fig. 3B, Table 1). On the other hand, b-asarone, asar-
aldehyde and AF showed weak inhibitory action at 50 mM (less 
than 50% inhibition). The reference agent, quercetin (degran-
ulation inhibitor, 20 mM), strongly inhibited b-hexosaminidase 
release (92.2%). 
In addition, the inhibitory action of A. gramineus on a de-
layed-type hypersensitivity in mice was evaluated. A treatment 
of hapten, picryl chloride, to the sensitized mice produces 
strong ear edema of delayed-type hypersensitivity. In this 
condition, when orally administered at 22.2-200 mg/kg, the 
ethanol extract of A. gramineus significantly inhibited the DTH 
response (29.9%) only at 200 mg/kg as shown in Fig. 4. The 
reference drug, prednisolone, potently inhibited DTH (80.5%) 
at 10 mg/kg. Therefore, it is suggested that A.gramineus pos-
sesses anti-allergic activity against the immediate-type as well 
as against the delayed-type hypersensitivity. 
DISCUSSION 
In the present investigation, inhibitions of 5-LOX inhibition 
and b-hexosaminidase release were studied for investigating 
anti-allergy activity in vitro. Leukotrienes (LT) are produced 
from arachidonic acid by 5-LOX. LTs are deeply involved in 
several allergic disorders such as asthma and atopic der-
matitis (Rubin and Mollison, 2007). Thus 5-LOX inhibitory 
activity was examined using a mast cell line (RBL-1). And it 
is well known that the immediate hypersensitivity reaction is 
provoked at least in part by histamine released from antigen-
stimulated mast cells and basophils. Along with a histamine 
release, b-hexosaminidase is also degranulated from the 
antigen-stimulated cells, which is frequently used as a bio-
marker of an immediate-type allergic response (Schuwartz 
et al., 1981; Marquadt and Wasserman, 1983). Thus, RBL-
2H3 cells were used and the amounts of b-hexosaminidase 
release were checked. On these parameters, A. gramineus 
and its constituents showed anti-allergic activity.
Many pharmacological studies have revealed that A. gra-
mineus and its major constituent, b-asarone, could protect 
brain damage, alleviate memory function and inhibit Alzheim-
er’s symptoms (Liao et al., 1998; Chun et al., 2008; Geng et al., 
2010; Pages et al., 2010; Zou et al., 2011). However, the anti-
allergic and anti-inflammatory activities of this plant material 
and its constituents including b-asarone were rarely demon-
strated. There have been reports of cyclooxygenase-1 inhibi-
tory action of trans-asarone (Momin et al., 2003) and passive 
cutaneous anaphylaxis inhibition of g-asarone (Hashimoto et 
al., 1994). To our best knowledge, this is the first report of the 
anti-allergic property of A. gramineus and the constituents.
In conclusion, the rhizomes of A. gramineus and its sev-
eral constituents possess anti-allergic activity in vitro against 
5-LOX-catalyzed LT production and antigen-induced b-hexos-
aminidase release from mast cell lines. In particular, 2,3-di-
hydro-4,5,7-trimethoxy-1-ethyl-2-methyl-3-(2,4,5-trimethoxy-
phenyl)indene (AI) showed strong inhibitory activity against 
these two parameters. b-Asarone, a major constituent of A. 
gramineus, also showed anti-allergic action. Moreover, A. gra-
mineus showed inhibitory activity on DTH reaction although 
the potency was not strong. It is suggested that b-asarone and 
2,3-dihydro-4,5,7-trimethoxy-1-ethyl-2-methyl-3-(2,4,5-trime-
thoxyphenyl)indene (AI) certainly contribute to the anti-allergic 
property of A. gramineus.
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